Status:
TERMINATED
Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Collaborating Sponsors:
Federal University of São Paulo
Conditions:
Invasive Fungal Infections
Invasive Aspergillosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of this study is to test prospectively the performance of an algorithm stratified by an index based on neutrophil counts in association with galactomannan assay and image tests to s...
Detailed Description
Neutropenia is a major risk factor for invasive fungal infections, particularly those caused by moulds, such as Aspergillus spp., Fusarium spp. and the Zygomycetes. Among neutropenic patients, these i...
Eligibility Criteria
Inclusion
- age 18 years or more
- acute myeloid leukemia or myelosysplasia undergoing induction remission or consolidation therapy
- allogeneic stem cell transplant recipients
Exclusion
- prior invasive mould infection
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00982540
Start Date
February 1 2010
End Date
December 1 2013
Last Update
January 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univ. Fed. Rio de Janeiro
Rio de Janeiro, Rio de Janeiro, Brazil, 21941913